Targeting lysyl oxidase reduces peritoneal fibrosis.
Abdominal surgery and disease cause persistent abdominal adhesions, pelvic pain, infertility and occasionally, bowel obstruction. Current treatments are ineffective and the aetiology is unclear, although excessive collagen deposition is a consistent feature. Lysyl oxidase (Lox) is a key enzyme requi...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5553776?pdf=render |
id |
doaj-e05ed63c7a5b49d6b351fb6517bf7a40 |
---|---|
record_format |
Article |
spelling |
doaj-e05ed63c7a5b49d6b351fb6517bf7a402020-11-25T01:35:14ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01128e018301310.1371/journal.pone.0183013Targeting lysyl oxidase reduces peritoneal fibrosis.Christopher R HarlowXuan WuMarielle van DeemterFiona GardinerCraig PolandRebecca GreenSana SarviPamela BrownKarl E KadlerYinhui LuJ Ian MasonHilary O D CritchleyStephen G HillierAbdominal surgery and disease cause persistent abdominal adhesions, pelvic pain, infertility and occasionally, bowel obstruction. Current treatments are ineffective and the aetiology is unclear, although excessive collagen deposition is a consistent feature. Lysyl oxidase (Lox) is a key enzyme required for crosslinking and deposition of insoluble collagen, so we investigated whether targeting Lox might be an approach to reduce abdominal adhesions.Female C57Bl/6 mice were treated intraperitoneally with multiwalled carbon nanotubes (NT) to induce fibrosis, together with chemical (ß-aminoproprionitrile-BAPN) or miRNA Lox inhibitors, progesterone or dexamethasone. Fibrotic lesions on the diaphragm, and expression of fibrosis-related genes in abdominal wall peritoneal mesothelial cells (PMC) were measured. Effects of BAPN and dexamethasone on collagen fibre alignment were observed by TEM. Isolated PMC were cultured with interleukin-1 alpha (IL-1α) and progesterone to determine effects on Lox mRNA in vitro.NT-induced fibrosis and collagen deposition on the diaphragm was ameliorated by BAPN, Lox miRNA, or steroids. BAPN and dexamethasone disrupted collagen fibres. NT increased PMC Lox, Col1a1, Col3a1 and Bmp1 mRNA, which was inhibited by steroids. Progesterone significantly inhibited IL-1α induced Lox expression by PMC in vitro.Our results provide proof-of-concept that targeting peritoneal Lox could be an effective approach in ameliorating fibrosis and adhesion development.http://europepmc.org/articles/PMC5553776?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Christopher R Harlow Xuan Wu Marielle van Deemter Fiona Gardiner Craig Poland Rebecca Green Sana Sarvi Pamela Brown Karl E Kadler Yinhui Lu J Ian Mason Hilary O D Critchley Stephen G Hillier |
spellingShingle |
Christopher R Harlow Xuan Wu Marielle van Deemter Fiona Gardiner Craig Poland Rebecca Green Sana Sarvi Pamela Brown Karl E Kadler Yinhui Lu J Ian Mason Hilary O D Critchley Stephen G Hillier Targeting lysyl oxidase reduces peritoneal fibrosis. PLoS ONE |
author_facet |
Christopher R Harlow Xuan Wu Marielle van Deemter Fiona Gardiner Craig Poland Rebecca Green Sana Sarvi Pamela Brown Karl E Kadler Yinhui Lu J Ian Mason Hilary O D Critchley Stephen G Hillier |
author_sort |
Christopher R Harlow |
title |
Targeting lysyl oxidase reduces peritoneal fibrosis. |
title_short |
Targeting lysyl oxidase reduces peritoneal fibrosis. |
title_full |
Targeting lysyl oxidase reduces peritoneal fibrosis. |
title_fullStr |
Targeting lysyl oxidase reduces peritoneal fibrosis. |
title_full_unstemmed |
Targeting lysyl oxidase reduces peritoneal fibrosis. |
title_sort |
targeting lysyl oxidase reduces peritoneal fibrosis. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2017-01-01 |
description |
Abdominal surgery and disease cause persistent abdominal adhesions, pelvic pain, infertility and occasionally, bowel obstruction. Current treatments are ineffective and the aetiology is unclear, although excessive collagen deposition is a consistent feature. Lysyl oxidase (Lox) is a key enzyme required for crosslinking and deposition of insoluble collagen, so we investigated whether targeting Lox might be an approach to reduce abdominal adhesions.Female C57Bl/6 mice were treated intraperitoneally with multiwalled carbon nanotubes (NT) to induce fibrosis, together with chemical (ß-aminoproprionitrile-BAPN) or miRNA Lox inhibitors, progesterone or dexamethasone. Fibrotic lesions on the diaphragm, and expression of fibrosis-related genes in abdominal wall peritoneal mesothelial cells (PMC) were measured. Effects of BAPN and dexamethasone on collagen fibre alignment were observed by TEM. Isolated PMC were cultured with interleukin-1 alpha (IL-1α) and progesterone to determine effects on Lox mRNA in vitro.NT-induced fibrosis and collagen deposition on the diaphragm was ameliorated by BAPN, Lox miRNA, or steroids. BAPN and dexamethasone disrupted collagen fibres. NT increased PMC Lox, Col1a1, Col3a1 and Bmp1 mRNA, which was inhibited by steroids. Progesterone significantly inhibited IL-1α induced Lox expression by PMC in vitro.Our results provide proof-of-concept that targeting peritoneal Lox could be an effective approach in ameliorating fibrosis and adhesion development. |
url |
http://europepmc.org/articles/PMC5553776?pdf=render |
work_keys_str_mv |
AT christopherrharlow targetinglysyloxidasereducesperitonealfibrosis AT xuanwu targetinglysyloxidasereducesperitonealfibrosis AT mariellevandeemter targetinglysyloxidasereducesperitonealfibrosis AT fionagardiner targetinglysyloxidasereducesperitonealfibrosis AT craigpoland targetinglysyloxidasereducesperitonealfibrosis AT rebeccagreen targetinglysyloxidasereducesperitonealfibrosis AT sanasarvi targetinglysyloxidasereducesperitonealfibrosis AT pamelabrown targetinglysyloxidasereducesperitonealfibrosis AT karlekadler targetinglysyloxidasereducesperitonealfibrosis AT yinhuilu targetinglysyloxidasereducesperitonealfibrosis AT jianmason targetinglysyloxidasereducesperitonealfibrosis AT hilaryodcritchley targetinglysyloxidasereducesperitonealfibrosis AT stephenghillier targetinglysyloxidasereducesperitonealfibrosis |
_version_ |
1725067652502650880 |